Min Investment:
Max Investment:
Target Investment:
Total Funding: $5M
Total Funding: $160M
Total Funding: $260M
Total Funding: $3M
Total Funding: $170M
Total Funding: $210M
Total Funding: $14M
Total Funding: $170M
2008
2008
NanoDimension is a venture capital firm investing in disruptive technologies at the convergence of the life, physical and data sciences. Focus on life science related investments at +ND. Joined in 2008 as the first employee of +ND’s Bay Area office. Currently serve on the board of directors of Emulate, Visby, Serotiny, Partillion and AIRNA, and observe on the boards of Inscripta, Lightcast and IonPath. Previously served as a board member at Icosavax (Nasdaq: ICVX) and SQZ (NYSE: SQZ), and observed on the board of ARMO (acquired by Lilly) and Twist (Nasdaq: TWST). Helped lead +ND’s investments in Orca and Octant.
2005 - 2008
2005 - 2008